BioCentury
ARTICLE | Distillery Techniques

Drug platforms

April 3, 2018 6:13 PM UTC

Nuclear-targeted, catalytically inactive Ruminococcus flavefaciens Cas13d could be used for therapeutic targeting of single-stranded RNAs and RNA splicing in cell nuclei. The fusion consists of Cas13d...